HIGHLIGHTS
- who: Co-transporter et al. from the Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Hofuf, Saudi Arabia, Department have published the paper: The Outcomes of Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A Systematic Review and meta-Analysis, in the Journal: (JOURNAL) of 24/02/2022
- what: In the preliminary literature review, the authors found that most of the relevant studies were not designed to compare the short-term and long-term outcomes of SGLT2I administration for diabetic patients with neuropathy.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.